We are live on ! Find out more
EWA

EverSource Wealth Advisors Portfolio holdings

AUM $2.97B
1-Year Est. Return 28.74%
This Fund
S&P 500
This Quarter Est. Return
+11.61%
1 Year Est. Return
+28.74%
3 Year Est. Return
+89.7%
5 Year Est. Return
10 Year Est. Return
AUM
$2.21B
AUM Growth
+$393M
Cap. Flow
+$218M
Cap. Flow %
9.84%
Top 10 Hldgs %
19.94%
Holding
4,413
New
404
Increased
2,760
Reduced
745
Closed
164

Sector Composition

Rank Sector Weight
1 Technology 12.54%
2 Financials 7.15%
3 Consumer Discretionary 5.77%
4 Industrials 3.78%
5 Healthcare 2.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNTB
3576
Connect Biopharma Holdings
CNTB
$137M
$1.55K ﹤0.01%
+1,582
New +$1.26K
SPT icon
3577
Sprout Social
SPT
$519M
$1.55K ﹤0.01%
74
+40
+118% +$848
LU icon
3578
Lufax Holding
LU
$1.3B
$1.54K ﹤0.01%
552
-52
-9% -$147
JMSB icon
3579
John Marshall Bancorp
JMSB
$335M
$1.54K ﹤0.01%
+83
New +$1.4K
QTRX icon
3580
Quanterix
QTRX
$177M
$1.54K ﹤0.01%
+231
New +$1.29K
RPT
3581
Rithm Property Trust
RPT
$95.4M
$1.52K ﹤0.01%
94
+67
+248% +$1.09K
QURE icon
3582
uniQure
QURE
$3.07B
$1.52K ﹤0.01%
109
KHPI
3583
Kensington Hedged Premium Income ETF
KHPI
$420M
$1.52K ﹤0.01%
+60
New +$1.46K
BVS icon
3584
Bioventus
BVS
$1.03B
$1.52K ﹤0.01%
229
+184
+409% +$1.3K
SRAD icon
3585
Sportradar
SRAD
$3.74B
$1.52K ﹤0.01%
54
+28
+108% +$665
IHI icon
3586
iShares US Medical Devices ETF
IHI
$3.34B
$1.51K ﹤0.01%
24
YQ
3587
17 Education & Technology Group
YQ
$19.5M
$1.51K ﹤0.01%
+687
New +$1.33K
OCGN icon
3588
Ocugen
OCGN
$434M
$1.5K ﹤0.01%
1,550
+267
+21% +$221
PLAY icon
3589
Dave & Buster's
PLAY
$364M
$1.5K ﹤0.01%
50
+49
+4,900% +$1.11K
FULC icon
3590
Fulcrum Therapeutics
FULC
$288M
$1.5K ﹤0.01%
+218
New +$1.17K
HLF icon
3591
Herbalife
HLF
$1.31B
$1.5K ﹤0.01%
174
+2
+1% +$15
MG icon
3592
Mistras Group
MG
$503M
$1.49K ﹤0.01%
186
+106
+133% +$892
DYN icon
3593
Dyne Therapeutics
DYN
$4.89B
$1.49K ﹤0.01%
156
+121
+346% +$1.33K
HBB icon
3594
Hamilton Beach Brands
HBB
$323M
$1.49K ﹤0.01%
83
+68
+453% +$1.21K
IART icon
3595
Integra LifeSciences
IART
$1.38B
$1.49K ﹤0.01%
121
-36
-23% -$523
MGRM
3596
DELISTED
Monogram Orthopaedics
MGRM
$1.48K ﹤0.01%
+511
New +$1.38K
CEVA icon
3597
CEVA Inc
CEVA
$954M
$1.47K ﹤0.01%
67
+66
+6,600% +$1.47K
NRIX icon
3598
Nurix Therapeutics
NRIX
$2.61B
$1.47K ﹤0.01%
+129
New +$1.39K
PUBM icon
3599
PubMatic
PUBM
$627M
$1.47K ﹤0.01%
118
+77
+188% +$812
SPHR icon
3600
Sphere Entertainment
SPHR
$5.77B
$1.46K ﹤0.01%
35
+24
+218% +$813

Similar funds

EverSource Wealth Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, EverSource Wealth Advisors held 4,413 positions worth $2.21B, up 22% from $1.82B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

EverSource Wealth Advisors deployed $218M of net new capital in Q2 2025, opening 404 new positions and adding to 2,760 existing holdings. Its largest new stake was Praxis Impact Large Cap Value ETF: 1,041,021 shares worth $29.5M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard International Dividend Appreciation ETF, an estimated $10.2M trimmed.

  • EverSource Wealth Advisors's largest Q2 2025 buy was Praxis Impact Large Cap Value ETF: 1,041,021 shares worth $29.5M.
  • EverSource Wealth Advisors added most to Vanguard 0-3 Month Treasury Bill ETF in Q2 2025, an estimated $9.75M increase.
  • EverSource Wealth Advisors's biggest Q2 2025 reduction was Vanguard International Dividend Appreciation ETF, cutting an estimated $10.2M.
  • EverSource Wealth Advisors fully exited State Street SPDR S&P Regional Banking ETF in Q2 2025, selling an estimated $2.75M.
  • EverSource Wealth Advisors's ten largest holdings make up 20% of its $2.21B portfolio in Q2 2025.
  • EverSource Wealth Advisors opened 404 new positions and closed 164 in Q2 2025.
  • EverSource Wealth Advisors's portfolio value rose 22% quarter-over-quarter to $2.21B.

Based on EverSource Wealth Advisors's 13F filing for Q2 2025, filed 13 Aug 2025.